Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tg Therapeutics (TGTX) Debt Ratio (2019 - 2025)

Tg Therapeutics has reported Debt Ratio over the past 7 years, most recently at 0.23 for Q4 2025.

  • Quarterly results put Debt Ratio at 0.23 for Q4 2025, down 45.4% from a year ago — trailing twelve months through Dec 2025 was 0.23 (down 45.4% YoY), and the annual figure for FY2025 was 0.23, down 45.4%.
  • Debt Ratio for Q4 2025 was 0.23 at Tg Therapeutics, down from 0.24 in the prior quarter.
  • Over the last five years, Debt Ratio for TGTX hit a ceiling of 0.49 in Q1 2023 and a floor of 0.04 in Q3 2021.
  • Median Debt Ratio over the past 5 years was 0.29 (2023), compared with a mean of 0.28.
  • Biggest five-year swings in Debt Ratio: crashed 80.85% in 2021 and later surged 735.99% in 2022.
  • Tg Therapeutics' Debt Ratio stood at 0.18 in 2021, then skyrocketed by 105.88% to 0.37 in 2022, then fell by 17.34% to 0.3 in 2023, then skyrocketed by 39.29% to 0.42 in 2024, then plummeted by 45.4% to 0.23 in 2025.
  • The last three reported values for Debt Ratio were 0.23 (Q4 2025), 0.24 (Q3 2025), and 0.35 (Q2 2025) per Business Quant data.